Cite

    Maressa A. Bruhn et al.. “Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.” International journal of cancer, vol. 135, no. 3, n.d., pp. 731–741. http://access.bl.uk/ark:/81055/vdc_100024832060.0x000049